Johnson & Johnson India Sales Declined 3% In 2017-18
Johnson & Johnson reported sales of Rs 5,828 crore in India for 2017-18
Its after-tax profit rose 18% to $98 million on other income
J&J medical device sales have been hit after Centre's move to cap prices
Johnson & Johnson is mired in a controversy surrounding the safety of its baby talcum powder
Johnson & Johnson's sales in India dipped 3 per cent in the year to March 2018, a regulatory filing showed on Thursday, as the US drug maker grappled with the country's stringent medical device pricing policies.